A decision analysis of follow-up and treatment algorithms for nonsolid pulmonary nodules

Radiology

Volumn 290, Issue 3, 2019, Pages 506-513

  Hammer, Mark M ^a   Palazzo, Lauren L ^b   Eckel, Andrew L ^b   Barbosa, Eduardo M ^b,c   Kong, Chung Yin ^b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALGORITHM; ARTICLE; DECISION SUPPORT SYSTEM; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; LUNG NODULE; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; SIMULATION; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; SURVIVAL TIME; DIAGNOSTIC IMAGING; LUNG; LUNG TUMOR; MIDDLE AGED; MORTALITY; MULTIPLE PULMONARY NODULES; STATISTICAL MODEL; X-RAY COMPUTED TOMOGRAPHY;

AGED; ALGORITHMS; DECISION MAKING, COMPUTER-ASSISTED; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIPLE PULMONARY NODULES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85060384197     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2018180867     Document Type: Article

References (35)

1. Yankelevitz DF, Yip R, Smith JP, et al. CT screening for lung cancer: nonsolid nodules in baseline and annual repeat rounds. Radiology 2015;277(2):555–564.
2. Henschke CI, Yip R, Smith JP, et al. CT screening for lung cancer: part-solid nodules in baseline and annual repeat rounds. AJR Am J Roentgenol 2016;207(6):1176–1184.
3. Benegas Urteaga M, Rosales-Mayor E, Gutierrez Chacoff J, et al. Lung adenocarcinoma based on IASLC/ATS/ERS International Multidisciplinary Classification: CT and PET findings with pathologic correlation. http://posterng.netkey.at/esr/viewing/index.php?module=viewing_poster&doi=10.1594/ecr2014/C-2159. Published 2014.
4. Gardiner N, Jogai S, Wallis A. The revised lung adenocarcinoma classification: an imaging guide. J Thorac Dis 2014;6(Suppl 5):S537–S546.
5. McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369(10):910–919.
6. Mortani Barbosa EJ Jr. Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated. Acad Radiol 2015;22(8):976–982.
7. Veronesi G, Maisonneuve P, Bellomi M, et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2012;157(11):776–784.
8. Kakinuma R, Noguchi M, Ashizawa K, et al. Natural history of pulmonary subsolid nodules: a prospective multicenter study. J Thorac Oncol 2016;11(7):1012–1028.
9. Kakinuma R, Muramatsu Y, Kusumoto M, et al. Solitary pure ground-glass nodules 5 mm or smaller: frequency of growth. Radiology 2015;276(3):873–882.
10. Lee SM, Park CM, Goo JM, Lee H-J, Wi JY, Kang CH. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features. Radiology 2013;268(1):265–273.
11. Scholten ET, de Jong PA, de Hoop B, et al. Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules? Eur Respir J 2015;45(3):765–773.
12. Hur J, Lee H-J, Nam JE, et al. Diagnostic accuracy of CT fluoroscopy-guided needle aspiration biopsy of ground-glass opacity pulmonary lesions. AJR Am J Roentgenol 2009;192(3):629–634.
13. Inoue D, Gobara H, Hiraki T, et al. CT fluoroscopy-guided cutting needle biopsy of focal pure ground-glass opacity lung lesions: diagnostic yield in 83 lesions. Eur J Radiol 2012;81(2):354–359.
14. Hattori A, Matsunaga T, Hayashi T, Takamochi K, Oh S, Suzuki K. Prognostic impact of the findings on thin-section computed tomography in patients with subcen-timeter non-small cell lung cancer. J Thorac Oncol 2017;12(6):954–962.
15. Moon Y, Sung SW, Namkoong M, Park JK. The effectiveness of mediastinal lymph node evaluation in a patient with ground glass opacity tumor. J Thorac Dis 2016;8(9):2617–2625.
16. American College of Radiology. Lung CT Screening Reporting and Data System (Lung-RADS). http://www.acr.org/Quality-Safety/Resources/LungRADS. Published 2014. Accessed June 19, 2016.
17. Martin MD, Kanne JP, Broderick LS, Kazerooni EA, Meyer CA. Lung-RADS: pushing the limits. RadioGraphics 2017;37(7):1975–1993.
18. Morrison JJ, Hostetter J, Wang K, Siegel EL. Data-driven decision support for radiologists: re-using the National Lung Screening Trial dataset for pulmonary nodule management. J Digit Imaging 2015;28(1):18–23.
19. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395–409.
20. Eguchi T, Bains S, Lee M-C, et al. Impact of increasing age on cause-specific mortality and morbidity in patients with stage i non-small-cell lung cancer: a competing risks analysis. J Clin Oncol 2017;35(3):281–290.
21. Powell HA, Tata LJ, Baldwin DR, Stanley RA, Khakwani A, Hubbard RB. Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit. Thorax 2013;68(9):826–834.
22. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 2004;125(1):27–37.
23. Jeon J, Meza R, Krapcho M, Clarke LD, Byrne J, Levy DT. Chapter 5: actual and counterfactual smoking prevalence rates in the U.S. population via microsimulation. Risk Anal 2012;32(Suppl 1):S51–S68.
24. Rosenberg MA, Feuer EJ, Yu B, et al. Chapter 3: cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Anal 2012;32(Suppl 1):S25–S38.
25. Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2016;11(1): 39–51.
26. Li M, Yang X, Chen Y, et al. Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis. OncoTargets Ther 2017;10:2885–2892.
27. Wao H, Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis. Syst Rev 2013;2(1):10.
28. Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Eur J Nucl Med Mol Imaging 2002;29(9):1166–1173.
29. Heyneman LE, Patz EF. PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer 2002;38(3):261–266.
30. Tramontano AC, Cipriano LE, Kong CY, et al. Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer. AJR Am J Roentgenol 2013;200(5):1020–1027.
31. McMahon PM, Kong CY, Johnson BE, et al. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology 2008;248(1):278–287.
32. de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160(5):311–320.
33. Hur C, Hayeck TJ, Yeh JM, et al. Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One 2010;5(3):e9483.
34. Chung K, Jacobs C, Scholten ET, et al. Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules. Eur Radiol 2017;27(11):4672–4679.
35. Pandharipande PV, Eisenberg JD, Avery LL, et al. Journal club: how radiation exposure histories influence physician imaging decisions: a multicenter radiologist survey study. AJR Am J Roentgenol 2013;200(6):1275–1283.